Radiotherapy and chemotherapy in pancreatic cancer. Topical issues and future perspectives.
Boz
Giovanni
G
Department of Radiotherapy, CRO, Aviano (PN), Italy. gboz.rt.cro@cro.it
De Paoli
Antonino
A
Innocente
Roberto
R
Rossi
Carlo
C
Tosolini
Gian Carlo
GC
Bassi
Claudio
C
Falconi
Massimo
M
Pederzoli
Paolo
P
Trovò
Mauro G
MG
D017024:Chemotherapy, Adjuvant / Q000379:methods; D002945:Cisplatin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality / Q000532:radiotherapy*; D018714:Radiotherapy, Adjuvant / Q000379:methods; D011881:Radiotherapy, Computer-Assisted / Q000379:methods; D015996:Survival Rate; D000093542:Gemcitabine
D007166:Immunosuppressive Agents; D003841:Deoxycytidine; D002945:Cisplatin; D005472:Fluorouracil; D000093542:Gemcitabine